The Market Is Leaving Us Unprepared for a Pandemic
As we face down what the World Health Organization calls “a new normal” of high-impact epidemics, researchers and public health officials find themselves at war with for-profit pharmaceutical companies.
In January, before the novel coronavirus COVID-19 had achieved official pandemic status, when it was still prompting little more than below-the-fold news articles about the outbreak in Wuhan, one spicy little quote in Nature from one of the world’s leading experts on this family of viruses, structural biologist Rolf Hilgenfeld, nevertheless stood out. “The total […]
Sorry, but this article is available to subscribers only. Please log in or become a subscriber.